Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-28Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-01Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07Human brain changes after first psilocybin use.Unknown journal · 2026-05-04Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09Standardization of Psilocybin Dosing in a Natural Product-Based Retreat Setting: A Practical Method for Dose Quantification and Adjustment Across SessionsResearch Square · 2025-11-16High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley ratsJournal of Psychopharmacology · 2025-09-21Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.Unknown journal · 2025-07-29FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-03-31Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-01-31A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Unknown journal · 2024-12-18Expert recommendations for Germany's integration of psychedelic-assisted therapy.Unknown journal · 2024-10-23Human brain changes after first psilocybin usebioRxiv · 2024-10-13Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distressFrontiers in Psychiatry · 2024-04-17Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionJournal of Psychopharmacology · 2024-03-21Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionPsychological Medicine · 2024-01-21The entropic heart: Tracking the psychedelic state via heart rate dynamicsbioRxiv · 2023-11-08Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2023-08-31Canalization and plasticity in psychopathology.Unknown journal · 2022-12-26Body mass index (BMI) does not predict responses to psilocybin.Journal of Psychopharmacology · 2022-11-13A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic Medicine · 2022-10-27The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-08-07Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-07-31From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-06Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-06-30A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-06-30Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-09Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant DepressionJournal of Humanistic Psychology · 2017-06-18Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The International Journal of Neuropsychopharmacology · 2016-07-04Broadband cortical desynchronization underlies the human psychedelic state.Journal of Neuroscience · 2013-08-31